Skip to content

Faculty profile

Mario Tiberi

Back to faculty
Associate ProfessorCellular and Molecular MedicineUniversity of Ottawa

Latest papers

  • The dopamine transporter antagonist vanoxerine inhibits G9a and suppresses cancer stem cell functions in colon tumors.

    Nature cancer · 2024

  • Aβ oligomers induce pathophysiological mGluR5 signaling in Alzheimer's disease model mice in a sex-selective manner.

    Science signaling · 2020

  • Laser Doppler Flowmetry to Study the Regulation of Cerebral Blood Flow by G Protein-Coupled Receptors in Rodents.

    Methods in molecular biology (Clifton, N.J.) · 2019

All 18 publications

Latest funding

  • Proteomic and Signaling Modalities of Dopamine D3 Receptor Polymorphic Variants

    NSERC · 2024 · Principal investigator

    $47,000
  • Defining the role of dopamine transporter in the hierarchical organization of colorectal tumors

    CIHR · 2023 · Co-investigator

    $1,086,300
  • The GPCR Retreat 2023

    CIHR · 2023 · Co-investigator

    $15,000
All 12 grants and awards

Profile data last refreshed on September 25, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.

Something wrong or missing on this profile? Suggest a correction